Related Experiment Video
Updated: May 19, 2026
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Urinary proteomics for early diagnosis in diabetic nephropathy
Petra Zürbig1, George Jerums, Peter Hovind
1mosaiques diagnostics GmbH, Hannover, Germany. zuerbig@mosaiques-diagnostics.com
Diabetes
|August 9, 2012
Summary
Urinary proteome analysis, using capillary electrophoresis-coupled mass spectrometry, can detect diabetic nephropathy (DN) up to five years earlier than standard methods. This early detection of DN involves identifying specific collagen fragments in urine.
Area of Science:
- Nephrology
- Proteomics
- Biomarker Discovery
Background:
- Diabetic nephropathy (DN) is a leading cause of kidney failure and dialysis.
- Early detection of DN is crucial for timely intervention and preventing end-stage renal disease.
- Current diagnostic methods, like urinary albumin, have limitations in early prediction.
Purpose of the Study:
- To evaluate urinary proteome analysis for early prediction of DN in diabetic patients.
- To assess the efficacy of a chronic kidney disease (CKD) biomarker classifier for DN detection.
- To identify novel urinary biomarkers for predicting DN progression.
Main Methods:
- Longitudinal cohort study of 35 patients with type 1 and type 2 diabetes.
- Capillary electrophoresis-coupled mass spectrometry (CE-MS) to profile the urinary low-molecular-weight proteome.
- Application of a previously validated CKD biomarker classifier to urine samples.
Main Results:
- Urinary proteome analysis predicted progression to macroalbuminuria with high accuracy (AUC 0.93), significantly outperforming urinary albumin (AUC 0.67).
- Specific collagen fragments were identified as key biomarkers, detectable 3-5 years before clinical signs of DN (macroalbuminuria).
- A decrease in collagen fragments preceded the increase in albumin excretion, indicating early pathological changes.
Conclusions:
- Urinary proteome analysis offers a noninvasive and highly sensitive tool for early DN risk assessment.
- Collagen fragments in urine serve as promising early warning biomarkers for diabetic nephropathy.
- This approach can facilitate earlier therapeutic strategies to delay or prevent renal replacement therapy.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:29Urine Studies I: Urinalysis
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...